Bryan Morton
InvestorOperating Partner at Essex Woodlands Healthcare Partners
Find your path to Bryan
17 people in our graph share verified history with Bryan — schools, employers, funds. One of them is your warm intro.
About
Bryan Morton is an Operating Partner at Essex Woodlands Healthcare Partners, which he joined in 2017 after a decade serving as CEO and Chairman of two EW portfolio companies. He has founded five specialty pharmaceutical companies, including EUSA Pharma (sold to Jazz Pharmaceuticals and later re-established before being acquired by Recordati), Zeneus Pharma, Izana Bio, and Akaza Bio, and previously held senior executive roles at Merck & Co and Bristol Myers Squibb. He holds an MBA from Durham University and a BS in Pharmacology from Aberdeen University, and was awarded a CBE in 2016.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
EUSA Pharma “I”EUSA Pharma “II”
Per the firm's website.
Colleagues at Essex Woodlands Healthcare Partners
Frequently asked questions
- Who is Bryan Morton?
- Bryan Morton is an Operating Partner at Essex Woodlands Healthcare Partners, which he joined in 2017 after a decade serving as CEO and Chairman of two EW portfolio companies. He has founded five specialty pharmaceutical companies, including EUSA Pharma (sold to Jazz Pharmaceuticals and later re-established before being acquired by Recordati), Zeneus Pharma, Izana Bio, and Akaza Bio, and previously held senior executive roles at Merck & Co and Bristol Myers Squibb. He holds an MBA from Durham University and a BS in Pharmacology from Aberdeen University, and was awarded a CBE in 2016.
- Where does Bryan Morton work?
- Bryan Morton is Operating Partner at Essex Woodlands Healthcare Partners.
- What does Bryan Morton invest in?
- Bryan Morton invests in Biotech.
- What boards does Bryan Morton sit on?
- Bryan Morton holds tracked board seats at EUSA Pharma “I”, EUSA Pharma “II”.